U.S. Residential REITs Stock News

Corning stock has delivered a very large 3 year gain while the valuation checks are split, with the Discounted Cash Flow (DCF) estimate pointing to upside relative to the current share price and the market multiples suggesting the stock now trades at a premium. Corning is up about 4.4x over the past 3 years, which puts extra focus on whether recent buyers are paying above the company’s underlying value. Fresh attention on U.S. semiconductor and data infrastructure, including recent policy...

Hercules Capital earnings and dividend get investor attention Hercules Capital (HTGC) recently reported second quarter and first half 2026 results alongside a new cash dividend, a combination that has put the stock on many income focused investors’ watchlists. See our latest analysis for Hercules Capital. At a share price of US$16.67, Hercules Capital has seen short term share price pressure with a 1 day decline of 2.91%. However, the 3 month share price return of 5.11% and 5 year total...

BJ's Wholesale Club Holdings has delivered a 78.1% total return over the past five years, yet its current share price of US$93.96 sits at a sizeable discount to an intrinsic value estimate based on a Discounted Cash Flow (DCF) model, with market multiples pointing in the same direction. The 78.1% return over five years suggests BJ's Wholesale Club Holdings has already rewarded patient shareholders, which makes the current valuation gap more striking. Expectations that the company can...

Penske Automotive Group stock has delivered a strong 182.4% total return over the past 5 years, yet the broader valuation checks suggest it no longer looks like an obvious bargain at current levels. At the same time, investors are weighing solid recent share price performance against questions over how much upside is left around the proposed US$210 per share take private offer. The 182.4% return over 5 years points to a stock that has already rewarded long term holders, which naturally...

Stryker stock has delivered a 37.0% gain over the past five years, yet the latest valuation checks suggest it is not an obvious bargain, even as an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach points to some upside versus the current share price. With the shares recently closing at US$348.15 and the company working through the financial impact of a cyberattack and order backlog, investors are now weighing a mixed valuation picture. Stryker’s 37.0% return over five...

Honeywell International recently presented at Deutsche Bank’s Chicago Industrials Summit, where CFO Mike Stepniak addressed investors, following Honeywell Aerospace’s earlier Q2 2026 update showing higher sales but lower adjusted earnings and reduced full-year guidance. The combination of mixed earnings and a weaker outlook for Honeywell Aerospace has sharpened attention on how the post-separation businesses may balance growth, profitability, and capital allocation priorities. We’ll now...

Century Aluminum earnings jump draws investor attention Century Aluminum (CENX) reported second quarter 2026 revenue of US$752.1 million and net income of US$249.3 million, compared with a net loss a year earlier, putting the stock firmly back on investor watchlists. See our latest analysis for Century Aluminum. Century Aluminum’s recent earnings have coincided with a 17.06% 1 month share price return and a 27.72% year to date share price return, while the 1 year total shareholder return of...

TeraWulf Inc. has already reported second-quarter 2026 results, with revenue slipping to US$44.77 million from US$47.64 million a year earlier and net loss widening to US$939.92 million, while six-month revenue eased to US$78.78 million and net loss expanded to about US$1.37 billion. These results highlight how construction complexity and pre-revenue costs tied to TeraWulf’s growing high-performance computing leasing footprint, including a US$19 billion Anthropic deal, are weighing heavily...

QUALCOMM (QCOM) has come under closer scrutiny after missing third quarter earnings estimates, reporting weaker handset revenue tied to memory supply issues and a lower modem share for the upcoming iPhone launch. See our latest analysis for QUALCOMM. QUALCOMM's share price has been under pressure recently, with a 30 day share price return that declined 14% and a 90 day share price return that declined 23.69%, even though the 1 year total shareholder return is 8.05% and the 3 year total...

Box stock has delivered a 33.9% return over the past five years, yet its valuation checks send mixed signals as the Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable gap to the current share price while market multiples lean the other way. A 33.9% five year return suggests Box has rewarded patient shareholders, so the current price reflects at least some confidence in its long term cash generation. Recent commentary around Box's AI security capabilities and enterprise...

In recent weeks, CELUS announced a partnership with Variscite that plugs Variscite’s NXP-based system‑on‑modules into the CELUS Design Platform and NXP Block Diagram Designer, while NXP revealed its Trimension NCJ29D6 UWB chips will feature in BMW’s 2026 vehicle programs for digital keys and in‑cabin presence detection. Alongside ongoing talks to acquire AI video‑chip maker Ambarella, these developments highlight how NXP is tying its automotive and edge portfolios more tightly into AI‑driven...

Caterpillar (CAT) just delivered its best quarter on record, with management lifting full year 2026 sales and revenue guidance to mid to high teens growth, supported by a US$72b backlog. See our latest analysis for Caterpillar. Caterpillar's latest results come after a sharp pullback in recent weeks, with the 30 day share price return down 11.45% and the 90 day share price return down 6.53%. At the same time, the year to date share price return is 40.94% and the 5 year total shareholder...

PTC Therapeutics, Inc. recently reported second-quarter 2026 results showing revenue of US$360.52 million and net income of US$83.5 million, while also raising its full-year 2026 total revenue outlook to US$1.18 billion–US$1.28 billion and appointing long-time executive Hege Sollie-Zetlmayer to its board of directors. The combination of a profitable quarter, higher revenue guidance, and added board experience from a former Chief Human Resources Officer may influence how investors assess PTC...

PNC Financial Services Group (PNC) is back in focus after PNC Bank opened its 50th new branch under a multi year, $2b expansion plan and hired industry veteran Arne Jahn to lead its metals and mining sector coverage. See our latest analysis for PNC Financial Services Group. Against this backdrop, PNC Financial Services Group’s recent business moves sit alongside a 90 day share price return of 21.14% and a 1 year total shareholder return of 37.32%. The 3 year total shareholder return of...

Ciena (CIEN) is back in focus after two recent networking announcements, as investors weigh what new DWDM deployments in the UAE and a quantum safe encryption trial in the US might mean for the stock. See our latest analysis for Ciena. Those two networking wins arrive after a sharp pullback in Ciena’s share price. It is down 32.94% over 90 days and 15.89% over 30 days, even though the year-to-date share price return is 57.49% and the 1-year total shareholder return is very large. This...

Hamilton Lane stock has fallen 32.6% over the past year, yet the current valuation checks now suggest the shares no longer look obviously expensive or obviously cheap. After this reset, investors are weighing a recent bounce against what the broader valuation picture implies for the next phase. Over the last 12 months the share price declined 32.6%, which puts recent gains into the context of a stock still well below where it traded a year ago. Hamilton Lane’s recent move to acquire a US$270...

The market just rewrote the Alamar Biosciences story in one session. The stock surged 30.7% to US$36.57 after its first post‑IPO quarter as a listed company, even though the business is still running losses. That kind of jump puts expectations on a different level. The headline from these earnings is simple. Revenue reached US$29.4m in Q2 and gross margin hit 60%, an all time high for the company, while Alamar reported a net loss of US$13.2m. For a high growth proteomics platform, this...

Becton, Dickinson and Company reported its third-quarter fiscal 2026 results, with sales rising to US$4,983 million while quarterly and year-to-date net income fell compared with the prior year, and it updated full-year 2026 guidance to expect low single-digit plus GAAP revenue growth. This was the first full quarter after spinning off its biosciences and diagnostics business, highlighting a more focused medical technology portfolio and new drug-delivery collaborations such as the...

HCA Healthcare stock has produced a 75.1% return over the past five years, yet current valuation checks suggest the shares may still trade at a discount to an estimate of intrinsic value based on a Discounted Cash Flow (DCF) approach and earnings multiples. At the same time, recent headlines around worker pay, staffing, leadership changes and new urgent care acquisitions give investors more to weigh as they think about what that valuation gap really reflects. A 75.1% return over five years...

In the second quarter of 2026, Turning Point Brands reported higher sales of US$142.96 million but lower net income of US$3.6 million, while also completing its February 2020 share repurchase program with 2,471,405 shares bought back for US$83.01 million. Despite the earnings pressure, the company raised its full-year 2026 Modern Oral guidance, lifting projected gross sales to US$330 million–US$350 million and net sales to US$260 million–US$270 million, underscoring the growing importance of...

Legend Biotech entered this earnings release as a pressured growth story, with the stock down sharply over the past three months. Today the mood shifted. Shares rose about 6% after the market absorbed a straightforward set of results. Q2 moved from a loss in Q1 to positive basic earnings per share and reported quarterly revenue of US$387.5m. For a biotech widely viewed as long on promise and short on profits, that move into positive earnings on a quarterly basis is the key detail. The rest of...

In the second quarter of 2026, Glaukos Corporation reported sales of US$185.61 million versus US$124.12 million a year earlier, with its basic loss per share from continuing operations narrowing to US$0.31 from US$0.34. Alongside this performance, Glaukos raised its 2026 net sales guidance to a range of US$680 million to US$700 million, signaling management’s increased confidence in the company’s revenue outlook despite ongoing losses. We’ll now explore how Glaukos’ raised full-year sales...

Berkshire Hathaway reported past second-quarter 2026 results showing revenue of US$101.81 billion and net income of US$25.67 billion, with earnings from continuing operations per share rising sharply from the prior year. Under new CEO Greg Abel, Berkshire shifted from hoarding cash to actively deploying capital through its largest share repurchases in nearly two years, renewed net stock buying, and sizable commitments such as a US$10 billion investment in Alphabet and the Taylor Morrison...

In August 2026, Schrödinger, Inc. reported that second-quarter 2026 revenue rose to US$58.89 million and swung from a prior-year loss to net income of US$5.98 million, while also filing a US$46.95 million shelf registration for 3,000,000 common shares related to its employee stock ownership plan. On the same day, Bristol Myers Squibb announced it would deploy Schrödinger’s agentic AI co-scientist Bunsen across its research organization, expanding a long-running collaboration and spotlighting...